ESMO Archives – CARE™ Education

News Oncology women's cancers

LBA36 - Association of PD-L1 expression and gene expression profiling with clinical response to pembrolizumab…

jwood@krftwrk.caNovember 14, 2018

Breast Cancer Medical Oncology News Oncology

290O - Patient-reported outcomes (PROs) in advanced breast cancer (ABC) treated with ribociclib + fulvestrant:…

jwood@krftwrk.caNovember 14, 2018

Breast Cancer Medical Oncology News Oncology

LBA12_PR - PERSEPHONE: 6 versus 12 months (m) of adjuvant trastuzumab in patients (pts) with…

jwood@krftwrk.caNovember 14, 2018

Lung Cancer Medical Oncology News Oncology

LBA50 - Mechanisms of acquired resistance to first-line osimertinib: preliminary data from the phase III…

jwood@krftwrk.caNovember 14, 2018

Medical Oncology News Oncology Sarcoma

LBA67 - Cabozantinib in patients with advanced osteosarcomas and Ewing sarcomas: a French Sarcoma Group…

jwood@krftwrk.caNovember 14, 2018